Following Priority Review and Breakthrough Therapy Designation, the U.S. Food and Drug Administration (FDA) has granted accelerated approval...

In continuation of my update on  alectinib ,  erlotinib and  osimertinib                                                                   ...

A subset of lung tumours is exquisitely sensitive to a class of recently approved anti-cancer drugs. Researchers at the CeMM Research Cent...

In continuation of my update on Ganetespib Ganetespib Shows Potency Against Lung Cancer

In continuation of my update on Erlotinib .. Dr. Narla's laboratory focuses on the identification and characterization of the gen...